Charles Schwab’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-109,717
Closed -$2.03M 3594
2023
Q3
$2.03M Sell
109,717
-49,161
-31% -$556K ﹤0.01% 2594
2023
Q2
$1.76M Sell
158,878
-175,291
-52% -$2.44M ﹤0.01% 2588
2023
Q1
$4.49M Buy
334,169
+56,461
+20% +$977K ﹤0.01% 2254
2022
Q4
$3.44M Buy
277,708
+115,573
+71% +$1.64M ﹤0.01% 2390
2022
Q3
$2.26M Buy
162,135
+215
+0.1% +$3.46K ﹤0.01% 2550
2022
Q2
$2.24M Sell
161,920
-15,940
-9% -$255K ﹤0.01% 2539
2022
Q1
$2.89M Buy
177,860
+112,541
+172% +$1.76M ﹤0.01% 2519
2021
Q4
$1.06M Sell
65,319
-4,892
-7% -$82.5K ﹤0.01% 2885
2021
Q3
$1.04M Sell
70,211
-116,382
-62% -$1.86M ﹤0.01% 2861
2021
Q2
$3.73M Buy
186,593
+9,553
+5% +$189K ﹤0.01% 2488
2021
Q1
$4.09M Sell
177,040
-25,661
-13% -$715K ﹤0.01% 2388
2020
Q4
$5.01M Buy
202,701
+1,631
+0.8% +$54K ﹤0.01% 2218
2020
Q3
$8.34M Sell
201,070
-2,833
-1% -$130K ﹤0.01% 1806
2020
Q2
$9.77M Buy
203,903
+36,086
+22% +$2.79M ﹤0.01% 1668
2020
Q1
$10.6M Buy
167,817
+4,006
+2% +$360K 0.01% 1415
2019
Q4
$20.3M Buy
163,811
+3,125
+2% +$280K 0.01% 1203
2019
Q3
$10.7M Buy
160,686
+10,301
+7% +$692K 0.01% 1572
2019
Q2
$12M Buy
150,385
+17,609
+13% +$1.58M 0.01% 1480
2019
Q1
$14.9M Buy
132,776
+12,317
+10% +$1.35M 0.01% 1313
2018
Q4
$12.1M Sell
120,459
-361
-0.3% -$37.4K 0.01% 1327
2018
Q3
$15.3M Buy
120,820
+10,015
+9% +$1.06M 0.01% 1348
2018
Q2
$9.3M Buy
110,805
+56,556
+104% +$4.14M 0.01% 1650
2018
Q1
$3.34M Buy
54,249
+8,471
+19% +$511K ﹤0.01% 2130
2017
Q4
$2.67M Sell
45,778
-2,751
-6% -$173K ﹤0.01% 2202
2017
Q3
$2.82M Sell
48,529
-13,643
-22% -$1.47M ﹤0.01% 2145
2017
Q2
$7.53M Sell
62,172
-2,131
-3% -$247K 0.01% 1544
2017
Q1
$7.27M Buy
64,303
+5,355
+9% +$625K 0.01% 1536
2016
Q4
$6.41M Sell
58,948
-1,384
-2% -$165K 0.01% 1571
2016
Q3
$9.93M Buy
60,332
+3,903
+7% +$615K 0.01% 1166
2016
Q2
$8.05M Buy
56,429
+9,112
+19% +$1.33M 0.01% 1223
2016
Q1
$6.08M Sell
47,317
-4,741
-9% -$560K 0.01% 1394
2015
Q4
$7.78M Buy
52,058
+4,776
+10% +$808K 0.01% 1194
2015
Q3
$7.84M Buy
47,282
+13,000
+38% +$2.86M 0.01% 1146
2015
Q2
$8.28M Buy
34,282
+5,411
+19% +$1.44M 0.01% 1186
2015
Q1
$8.14M Buy
28,871
+3,909
+16% +$847K 0.01% 1149
2014
Q4
$3.9M Buy
24,962
+1,910
+8% +$353K 0.01% 1619
2014
Q3
$5.46M Buy
23,052
+6,173
+37% +$1.57M 0.01% 1291
2014
Q2
$4M Sell
16,879
-9,620
-36% -$2.54M 0.01% 1571
2014
Q1
$8.74M Buy
26,499
+4,689
+21% +$1.58M 0.02% 900
2013
Q4
$1.49M Buy
21,810
+2,546
+13% +$147K ﹤0.01% 2071
2013
Q3
$1.48M Buy
19,264
+1,713
+10% +$84.6K ﹤0.01% 2013
2013
Q2
$771K Buy
+17,551
New +$600K ﹤0.01% 2305